TEVA

#394
Teva Pharmaceutical Industries Limited American Depositary Shares
30.9650 USD
+0.47%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
30.9150
31.0000
1年のレンジ
19.0100
37.3400
1日の変化
+0.47%
月次変化
+6.67%
6か月変化
+62.08%
1年の変化
+62.08%
以前の終値
30.8200
始値
30.9200
Bid
Ask
安値
30.9150
High
31.0000
ボリューム
194
チャート全体を表示

Financials

概要 明細書 統計 配当金
期次 年次
  • Market Capitalization 35.604 B
  • Employee 33 K
  • Founded N/A
  • CEO Richard Francis
  • Website www.tevapharm.com
  • Headquarter Israel
  • FIGI BBG000C0CD58
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
25.79
売上高対価格比率
2.1

Teva Pharmaceutical Industries Limited American Depositary Shar

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs.

ニュース